ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 217 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $8,785,556 | -6.4% | 338,036 | +3.0% | 0.00% | 0.0% |
| Q1 2024 | $9,381,744 | -11.0% | 328,033 | -4.8% | 0.00% | 0.0% |
| Q4 2023 | $10,541,823 | +47.5% | 344,504 | +29.5% | 0.00% | 0.0% |
| Q3 2023 | $7,145,969 | -34.2% | 265,946 | -12.7% | 0.00% | -25.0% |
| Q2 2023 | $10,865,138 | +154212.4% | 304,687 | +9.9% | 0.00% | +33.3% |
| Q1 2023 | $7,041 | -55.6% | 277,226 | -29.2% | 0.00% | -50.0% |
| Q4 2022 | $15,872 | -99.9% | 391,327 | -17.9% | 0.01% | 0.0% |
| Q3 2022 | $15,744,000 | -36.1% | 476,375 | -32.0% | 0.01% | -40.0% |
| Q2 2022 | $24,656,000 | -14.6% | 700,276 | +10.1% | 0.01% | +11.1% |
| Q1 2022 | $28,872,000 | -15.3% | 635,934 | +23.8% | 0.01% | -10.0% |
| Q4 2021 | $34,069,000 | +12.0% | 513,850 | +5.5% | 0.01% | +11.1% |
| Q3 2021 | $30,413,000 | -28.1% | 487,163 | -4.6% | 0.01% | -30.8% |
| Q2 2021 | $42,311,000 | +20.4% | 510,873 | -3.6% | 0.01% | +18.2% |
| Q1 2021 | $35,155,000 | -35.5% | 530,158 | -25.4% | 0.01% | -38.9% |
| Q4 2020 | $54,505,000 | +78.0% | 710,348 | -0.1% | 0.02% | +50.0% |
| Q3 2020 | $30,621,000 | -9.2% | 711,126 | -8.9% | 0.01% | -14.3% |
| Q2 2020 | $33,732,000 | +71.1% | 781,001 | +13.9% | 0.01% | +40.0% |
| Q1 2020 | $19,719,000 | -16.4% | 685,397 | +84.3% | 0.01% | +11.1% |
| Q4 2019 | $23,589,000 | +112.4% | 371,901 | -5.6% | 0.01% | +125.0% |
| Q3 2019 | $11,104,000 | +12.7% | 394,022 | +6.0% | 0.00% | 0.0% |
| Q2 2019 | $9,854,000 | – | 371,862 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $93,815,000 | 51.06% |
| Aquilo Capital Management, LLC | 436,514 | $12,559,000 | 4.90% |
| Vivo Capital, LLC | 768,674 | $22,115,000 | 2.00% |
| ACUTA CAPITAL PARTNERS, LLC | 109,700 | $3,156,000 | 1.53% |
| Prosight Management, LP | 104,737 | $3,013,000 | 1.41% |
| Capital Impact Advisors, LLC | 84,537 | $2,432,000 | 1.02% |
| Artal Group S.A. | 600,000 | $17,262,000 | 0.73% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 62,000 | $1,784,000 | 0.48% |
| Quantitative Investment Management, LLC | 150,401 | $4,327,000 | 0.47% |
| OAK RIDGE INVESTMENTS LLC | 131,502 | $3,784,000 | 0.39% |